
Hologic Investor Relations Material
Latest events

Q2 2025
Hologic
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Hologic Inc
Access all reports
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. The company offers technologies for mammography, 3D breast tomosynthesis (MammoSite(TM)), and FDA-cleared digital breast tomosynthesis (3D mammography); gynecologic imaging systems; and instruments for gynecology procedures; as well as software for diagnostic oncology centers and breast imaging. It also provides surgical services to support pre-, intra-, and postoperative care by surgeons or oncologists; preoperative planning tools for tumor management; and pathology review tools. In addition, the company offers facial aesthetics products comprising of injection devices designed to enhance aesthetics in patients undergoing anti-aging or cosmetic treatments such as neuromodulators that are used to smooth wrinkles and fine lines around the eyes.
Key slides for Hologic Inc


Q2 2025
Hologic Inc


Q2 2025
Hologic Inc
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
HOLX
Country
🇺🇸 United States